Source | Colorectal cancer (No. cases in NSWCR: 2253) | Lung cancer (No. cases in NSWCR: 1019) | ||||||
---|---|---|---|---|---|---|---|---|
No. cases identified | PPV | Sensitivity | Specificity | No. cases identified | PPV | Sensitivity | Specificity | |
Individual indicators | ||||||||
APDC diagnosis of cancer | 2338 | 91% | 95% | 99.9% | 968 | 85% | 81% | 100.0% |
APDC diagnosis of history of primary cancer | 2487 | 24% | 26% | 99.5% | 166 | 23% | 4% | 100.0% |
APDC surgical resection | 3376 | 54% | 81% | 99.4% | 400 | 60% | 23% | 99.9% |
APDC chemotherapy | 1333 | 12% | 7% | 99.6% | 1333 | 6% | 7% | 99.5% |
APDC radiotherapy | 456 | 4% | 1% | 99.8% | 456 | 14% | 6% | 99.9% |
EDDC diagnosis of primary cancer | 27 | 44% | 1% | 100.0% | 56 | 50% | 3% | 100.0% |
MBS surgical resection | 1793 | 59% | 47% | 99.7% | 310 | 45% | 14% | 99.9% |
MBS radiotherapy item | 6051 | 3% | 9% | 97.8% | 6051 | 5% | 33% | 97.9% |
MBS chemotherapy item | 4940 | 12% | 27% | 98.4% | 4940 | 7% | 35% | 98.3% |
PBS chemotherapy drug item | 1663 | 46% | 34% | 99.7% | 2082 | 14% | 28% | 99.3% |
COD-URF death record with primary cancer type | 364 | 36% | 6% | 99.9% | 609 | 62% | 37% | 100.0% |
Combinations of indicators | ||||||||
APDC cancer diagnosis or history of cancer | 3254 | 65% | 94% | 99.6% | 1016 | 81% | 81% | 99.9% |
APDC cancer diagnosis or surgery | 3738 | 57% | 95% | 99.4% | 1119 | 74% | 81% | 99.9% |
APDC cancer diagnosis and surgery | 1933 | 94% | 80% | 100.0% | 246 | 96% | 23% | 100.0% |
APDC cancer diagnosis and APDC chemotherapy or radiotherapy | 201 | 83% | 7% | 100.0% | 145 | 83% | 12% | 100.0% |
APDC or EDDC diagnosis of primary cancer | 2345 | 91% | 95% | 99.9% | 980 | 84% | 81% | 100.0% |
MBS or PBS chemotherapy or radiotherapy | 9144 | 9% | 38% | 96.9% | 9178 | 5% | 49% | 96.8% |
APDC cancer diagnosis and MBS/PBS chemotherapy or radiotherapy | 963 | 86% | 37% | 100.0% | 526 | 79% | 41% | 100.0% |
APDC cancer diagnosis and COD-URF primary cancer | 242 | 52% | 6% | 100.0% | 483 | 71% | 34% | 100.0% |
APDC cancer diagnosis or COD-URF primary cancer | 2370 | 90% | 95% | 99.9% | 1042 | 83% | 84% | 99.9% |